Ghode Dewang B, Hirani Shoyeb, Kenjale Sneha, Heda Arjun, Hirani Sajid, Prasad Roshan, Wanjari Mayur
General Surgery, Jawaharlal Nehru Medical College, Datta Meghe Institute of Higher Education and Research, Wardha, IND.
Medicine, Mahatma Gandhi Memorial (MGM) Medical College and Hospital, Aurangabad, IND.
Cureus. 2023 Aug 13;15(8):e43408. doi: 10.7759/cureus.43408. eCollection 2023 Aug.
Pyoderma gangrenosum (PG) is a challenging cutaneous manifestation associated with Dubowitz syndrome, a rare genetic disorder characterized by multiple congenital anomalies, developmental delay, and distinctive facial features. This review article aims to provide a comprehensive overview of the association between Dubowitz syndrome and pyoderma gangrenosum, emphasizing the clinical presentation, challenges in diagnosis and management, and potential underlying mechanisms. A comprehensive literature search was conducted to gather relevant studies, and inclusion and exclusion criteria were applied to select appropriate articles. The association between Dubowitz syndrome and pyoderma gangrenosum has been documented in reported cases and studies. Clinical characteristics of Pyoderma gangrenosum in Dubowitz syndrome include painful necrotic ulcers with undermined borders. Diagnosing pyoderma gangrenosum in the context of Dubowitz syndrome can be challenging due to the overlapping clinical features and complexities associated with the syndrome. Managing pyoderma gangrenosum involves a multidisciplinary approach, with general principles of wound care, systemic therapy, and pain management. Specific considerations for treating pyoderma gangrenosum in Dubowitz syndrome include collaboration among specialists and careful monitoring. Future directions for management include further research to understand the underlying mechanisms and develop targeted therapies. Recognizing and addressing pyoderma gangrenosum in Dubowitz syndrome is crucial for optimal patient care. This review enhances awareness among healthcare professionals and provides insights for improving diagnosis, management, and treatment outcomes for individuals with this challenging combination of conditions.
坏疽性脓皮病(PG)是一种与杜波维茨综合征相关的具有挑战性的皮肤表现,杜波维茨综合征是一种罕见的遗传性疾病,其特征为多种先天性异常、发育迟缓及独特的面部特征。这篇综述文章旨在全面概述杜波维茨综合征与坏疽性脓皮病之间的关联,重点阐述临床表现、诊断和管理中的挑战以及潜在的发病机制。进行了全面的文献检索以收集相关研究,并应用纳入和排除标准来选择合适的文章。杜波维茨综合征与坏疽性脓皮病之间的关联已在报告的病例和研究中得到记载。杜波维茨综合征中坏疽性脓皮病的临床特征包括边界呈潜行性的疼痛性坏死性溃疡。在杜波维茨综合征背景下诊断坏疽性脓皮病具有挑战性,因为该综合征存在重叠的临床特征且情况复杂。坏疽性脓皮病的管理需要多学科方法,包括伤口护理、全身治疗和疼痛管理的一般原则。在杜波维茨综合征中治疗坏疽性脓皮病的特殊考虑因素包括专家之间的协作和仔细监测。未来的管理方向包括进一步研究以了解潜在机制并开发靶向治疗。认识并处理杜波维茨综合征中的坏疽性脓皮病对于优化患者护理至关重要。这篇综述提高了医疗专业人员的认识,并为改善患有这种具有挑战性的病症组合的个体的诊断、管理和治疗结果提供了见解。